Evidence map›Paper›PMID 40806148›Full record

ArticleNutrients2025

Anticancer Activity of

Özlem Türksoy-Terzioğlu, Feyza Tosya, Ayşe Büşranur Çelik, Sibel Bölek, Levent Gülüm, Gökhan Terzioğlu, Yusuf Tutar

Abstract read
In one paragraph

Article in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Transcriptional Reprogramming of Cancer Metabolism:International journal of molecular sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Özlem Türksoy-TerzioğluDepartment of Molecular Biology and Genetics, Hamidiye Institute of Health Sciences, University of Health Sciences-Turkey, Istanbul 34668, Türkiye.
Feyza TosyaExperimental Medicine Research and Application Center, University of Health Sciences Turkey, Istanbul 34662, Türkiye.ORCID 0000-0003-2649-6721
Ayşe Büşranur ÇelikDepartment of Molecular Biology and Genetics, Hamidiye Institute of Health Sciences, University of Health Sciences-Turkey, Istanbul 34668, Türkiye.ORCID 0009-0005-7771-2414
Sibel BölekExperimental Medicine Research and Application Center, University of Health Sciences Turkey, Istanbul 34662, Türkiye.ORCID 0000-0003-4967-9416
Levent GülümDepartment of Plant and Animal Production, Mudurnu Süreyya Astarcı Vocational College, Bolu Abant İzzet Baysal University, Bolu 14030, Türkiye.
Gökhan TerzioğluDepartment of Medical Biology, Hamidiye International School of Medicine, University of Health Sciences, Istanbul 34899, Türkiye.
Yusuf TutarDepartment of Basic Medical Sciences, Division of Medical Biochemistry, Faculty of Medicine, Recep Tayyip Erdogan University, Rize 53100, Türkiye.ORCID 0000-0003-2613-9644

Funding

Recep Tayyip Erdoğan University 02025004015424
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Agents, PhytogenicPlant ExtractsSeedsStomach NeoplasmsVitexAntioxidantsApoptosisCell Line, TumorCell MovementCell ProliferationCell SurvivalFlavonoidsHumansMembrane Potential, MitochondrialPhenolsAntineoplastic Agents, PhytogenicAntioxidantsFlavonoidsPhenolsPlant Extractsapoptosiscytotoxicityepithelial–mesenchymal transition (EMT)gastric cancerVitex agnus-castus

Identifiers

PMID40806148
PMCPMC12348331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.